CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Open-market sale Director sold 5,000 shares at $63.76 ($318,800)
- 4 Open-market sale Director sold 5,000 shares at $65.24 ($326,200)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 5,000 shares at $89.85 ($449,250)
- 4 Open-market sale Chief Commercial Officer sold 3,625 shares at $89.22 ($323,423)
- 4 Open-market sale Director sold 4,500 shares at $89.21 ($401,445)
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Shareholder vote results
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Director sold 1,125 shares at $88.73 ($99,821)
- 4 Open-market sale General Counsel sold 90,000 shares at an average $88.46 ($7,961,240)
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
Page 20 of 69 · 1,363 filings